Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PHARMAIDS PH Gains 10%; BSE HEALTHCARE Index Up 0.3%
Tue, 5 Nov 9:26

PHARMAIDS PH Gains 10%; BSE HEALTHCARE Index Up 0.3%Image source: Kameleon007 /www.istockphoto.com

PHARMAIDS PH share price has zoomed 10% and is presently trading at Rs 65.3.

Meanwhile, the BSE HEALTHCARE index is at 44,001.7 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 5.7%) and GLAND PHARMA (up 2.1%).

MAX HEALTHCARE INSTITUTE (down 1.7%) and FORTIS HEALTHCARE (down 1.2%) are among the top losers today.

Over the last one year, PHARMAIDS PH has moved up from Rs 46.0 to Rs 65.3, registering a gain of Rs 19.3 (up 42.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,350.0 to 44,001.7, registering a gain of 60.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 230.6%), SUVEN PHARMACEUTICALS (up 131.5%) and Glenmark Pharma (up 131.5%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,750.4 .

The top losers among the BSE Sensex today are HDFC Bank (down 0.6%) and Reliance Ind. (down 0.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,007.0 (up 0.1%). JSW Steel and Hindalco are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,591.3 to 78,750.4, registering a gain of 15,159.1 points (up 23.8%).

PHARMAIDS PH Financial Update...

PHARMAIDS PH net profit fell 133.5% YoY to Rs -31 million for the quarter ended June 2024, compared to a loss of Rs 13 million a year ago. Net sales rose 100.0% to Rs 47 million during the period as against Rs 0 million in April-June 2023.

For the year ended March 2024, PHARMAIDS PH reported 56.7% decrease in net profit to Rs -118 million compared to net loss of Rs 76 million during FY23. Revenue of the company grew 100.0% to Rs 151 million during FY24.

The current Price to earnings ratio of PHARMAIDS PH, based on rolling 12 month earnings, stands at -19.9.


Equitymaster requests your view! Post a comment on "PHARMAIDS PH Gains 10%; BSE HEALTHCARE Index Up 0.3%". Click here!